Agrochemicals company Sharda Cropchem announced Q3FY25 results Revenue: Rs 929.3 crore compared to Rs 632.5 crore during Q3FY24, change 47%. Gross Profit: Rs 304.2 crore compared to Rs 165.6 crore during Q3FY24, change 84%. Gross Profit Margin: 32.7% for Q3FY25. EBITDA: Rs 156.6 crore compared to Rs 47.2 crore. EBITDA Margin: 16.9% for Q3FY25. PAT: Rs 31.1 crore compared to Rs 4.6 crore during Q3FY24. Ramprakash Bubna, Chairman and MD, said: “Despite the ongoing global headwinds and persistent pricing pressures, we have seen a revival in demand which has led to a strong performance in Q3FY25 Revenue in Q3FY25 increased by 47%, primarily driven by higher volumes. We saw volume growth across all regions, with Europe, NAFTA and LATAM being key drivers. Agrochemical volumes grew by 49.5% in Q3FY25. With raw material prices stabilising, we have managed to expand the gross margin by 660 bps to 32.7%. We have been working on cost optimization strategies and with operating leverage playing out, we have been able to improve our EBITDA Margins to 16.9% for the quarter. Our strong pipeline of registrations showcases our resilience and our commitment to growth which establishes a solid foundation for continued progress. We are confident on our ongoing plan to increase product registrations in FY25 with capex guidance of Rs 400-450 crore enabling us to meet FY25 guidance.” Result PDF
Agrochemicals company Sharda Cropchem announced Q2FY25 results Financial Highlights: Revenue: Rs 776.9 crore, compared to Rs 580.8 crore during the period Q2FY24, change 34%. Gross profit: Rs 214.7 crore, compared to Rs 145.5 crore during the period Q2FY24, change 48%. Gross profit Margin: 25.1%. EBITDA: Rs 84.4 crore, compared to Rs 37.7 crore during the period Q2FY24, change 125%. EBITDA margin: 6.5%. PAT: Rs 42.4 crore, compared to Rs -27.6 crore during the period Q2FY24. Business Highlights: Agrochemical Segment contributes 82%; Non-Agrochemical Segment contributes 18%. Overall Volumes have increased by 20.6% YoY in Q2FY25; Agrochemical volumes grew by 24.6% Agrochemical Segment contributes 84%; Non-Agrochemical Segment contributes 16%. Overall Volumes have increased by 30.3% YoY in H1FY25; Agrochemical volumes grew by 36.0%. Capex in H1FY25 stands at ~Rs. 155 crore. Product Registrations stand at 2,934 with 1,034 applications globally pending at various stages as on 30th September 2024. We remain a debt free company with cash, bank & liquid investments of Rs. 656 crore. Ramprakash Bubna, Chairman and MD, said: “Despite the global industry challenges, including subdued demand and pricing pressures, we have delivered strong performance in Q2 and H1FY25 compared to last year. Revenue in Q2FY25 increased by 34%, and H1FY25 by 28%, primarily driven by higher volumes and a gradual price increase. We saw volume growth across all regions, with Europe and NAFTA being key contributors. Agrochemical volumes grew by 24.6% in Q2FY25 and by 36.0% in H1FY25. We are optimistic about improving gross margins moving forward. Our extensive pipeline of registrations showcases our resilience and our commitment to growth. To drive sustainable growth, we intensify our focus on operational efficiencies. This enhances profitability and organizational agility, ensuring a strong foundation for future growth. We are happy to emphasize our ongoing plan to increase product registrations in FY25 with capex guidance of Rs. 400-450 crore is on track driving revenue growth, improved competitiveness, and increased customer satisfaction.” Result PDF
Conference Call with Sharda Cropchem Management and Analysts on Q1FY25 Performance and Outlook. Listen to the full earnings transcript.
Agrochemicals company Sharda Cropchem announced Q1FY25 results: Revenue: Rs 785.1 crore (up 23% YoY) Gross Profit: Rs 228.9 crore (up 311% YoY) Gross Profit Margin (%): 29.2% (up from 8.7% in Q1FY24) EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization): Rs 88.3 crore (from -Rs 66.0 crore in Q1FY24) EBITDA Margin (%): 11.3% (improvement from -10.4% in Q1FY24) PAT (Profit After Tax): Rs 27.3 crore (from -Rs 88.6 crore in Q1FY24) Commenting on the Results, Ramprakash Bubna, Chairman and MD, said : “In Q1FY25, we recorded an improvement in financial results on YoY basis despite a challenging market environment. Revenue has grown by 23% majorly due to growth in volumes by 41% as compared to last year. We have seen volume growth across all major regions with Europe nearly doubling. Volumes from Agrochemicals grew by 49%. Gross Margins at 29.2% have come back to normalcy and we expect this to improve in this financial year with prices expected to increase. This enhances profitability and organisational agility, ensuring a strong foundation for future growth. As we look ahead, we aim to increase our product registrations and expect Capex of ~Rs 400-450 crores on the same in FY25 and expand our global presence.” Result PDF